EP3661954
Hvítfrumuboða-21 stökkbreytt prótín og aðferðir til meðhöndlunar
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
3.8.2018EP published:
9.2.2022EP application number:
18759207.6
EP translation filed:
23.3.2022Grant published:
15.4.2022EPO information:
European Patent Register
Max expiry date:
2.8.2038Expiry date:
2.8.2026Next due date:
31.8.2026
Title in English:
INTERLEUKIN-21 MUTEINS AND METHODS OF TREATMENTLanguage of the patent:
English
Timeline
Today
3.8.2018EP application
9.2.2022EP Publication
23.3.2022Translation submitted
15.4.2022Registration published
2.8.2026Expires
Owner
Name:
Amgen Inc.Address:
One Amgen Center Drive, Thousand Oaks, California 91320-1799, US
Inventor
Name:
ALI, Khaled, M.K.Z.Address:
Thousand Oaks CA 91320, US
Name:
AGRAWAL, Neeraj, JagdishAddress:
Thousand Oaks CA 91320, US
Name:
KANNAN, GunasekaranAddress:
Thousand Oaks CA 91320, US
Name:
FOLTZ, IanAddress:
Thousand Oaks CA 91320, US
Name:
WANG, ZhulunAddress:
Thousand Oaks CA 91320, US
Name:
BATES, DarenAddress:
Thousand Oaks CA 91320, US
Name:
MOCK, MarissaAddress:
Thousand Oaks CA 91320, US
Name:
TAKENAKA, ShunsekeAddress:
Thousand Oaks CA 91320, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201762540692 PDate:
3.8.2017Country:
US
Number:
201862616733 PDate:
12.1.2018Country:
US
Classification
Categories:
C07K 14/54, A61K 47/60, A61K 47/54
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 19.8.2022
Expires: 2.8.2023
Payer: Árnason Faktor ehf.
Number: 6
Paid: 20.7.2023
Expires: 2.8.2024
Payer: Árnason Faktor ehf.
Number: 7
Paid: 23.7.2024
Expires: 2.8.2025
Payer: Árnason Faktor ehf.
Number: 8
Paid: 5.8.2025
Expires: 2.8.2026
Payer: Árnason Faktor ehf.